Risk Factors of Coronavirus Disease-19 (Covid-19) Patients
DOI:
https://doi.org/10.53089/medula.v12i4.581Keywords:
Risk Factor, Covid-19Abstract
Coronavirus disease-19 (Covid-19) is a disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus that has caused a worldwide pandemic and reached Indonesia in March 2020. This disease causes a various clinical manifestations from mild to severe, one of which also depends on risk factors that can exacerbate Covid-19 patients to the point of causing death. Risk factors that are often associated with Covid-19 diseases, such as age, race and ethnicity, gender, obesity, history of hypertension, chronic obstructive pulmonary disease (COPD), and diabetes mellitus. This is also related to the entry of viruses into the body that uses angiotensin-converting enzyme-2 (ACE-2), causing various risk factors to appear. This article is a literature review that was compiled using articles as references that were used between 2020-2022.
References
Kemenkes. Data Sebaran Covid-19 di Indonesia. 2022. Tersedia dari https://covid19.go.id.
Alkautsar A. Hubungan Penyakit Komorbid dengan Tingkat Keparahan Pasien Covid-19. Jurnal Medika Hutama. 2021. Tersedia dari: https://jurnalmedikahutama.com/in dex.php/JMH/article/view/302.
Ichsan MN, Kusadhiani I, Latuconsina VZ. Hubungan Komorbid dengan Durasi Perawatan pasien Covid-19 pada RS Bayangkara dan RS Tk. II Pro. Dr. JA. Latumen di Kota Ambon tahun 2020. Molucca Medica. 2022.
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A et al. Covid-19 and Cardiovascular Disease. Circulation AHA Journal. 2020. doi: 10.1161/CIRCULA TIONAHA.120.046941.
CDC. Underlying Medical Conditions Covid-19. Centers for Disease Control and Prevention. 2022. [diperbaharui 5 Mei 2022] Tersedia dari: https://www.cdc.gov/ coronavirus/2019-ncov/hcp/clinicalcare/ underlyingconditions.html.
Kabarriti R, Brodin NP, Maron MI, Chan, Guha, et al. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York. JAMA Netw Open. 2020. doi:10.1001/jamanet workopen.2020.19795.
Ko JY, Danielson ML, Town M, Derado G, Greenlund KJ, Kirley PD, et al. COVID-NET Surveillance Team, Risk Factors for Coronavirus Disease 2019 (COVID-19)–Associated Hospitalization: COVID-19–Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System, Clinical Infectious Diseases. 2021; 72(11): 695-703, doi: https://doi.org/10.1093 /cid/ciaa1419.
Sitorus RJ, Antara NY, Elviani R, Ahmad Z, Hudari H, Sangalang RV. The Risk Factor For Mortality in Covid-19 Patients in Mohammad Hoesin Hospital, Palembang, Indonesia. Jurnal Ilmu Kesehatan Masyarakat. 2021. doi: https://doi.org/10.26553/jikm.2021.12.1.69-76.
Gao YD, Ding M, Dong X, Zhang JJ, Azkur AK, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021. doi: https://doi.org/10.1111/all.14657.
Gao F, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, et al. Obesity Is a Risk Factor for Greater COVID-19 Severity. Diabetes Care. 2020. doi: https://doi.org/10.2337/dc20-0682.
Matsushita K, Ding N, Kou M, Hu X, Chen M, Gao Y, et al. The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis. Global heart. 2020. doi: https:// doi.org /10.5334/gh.814.
Fadl N, Ali E, Salem TZ. COVID-19: Risk Factors Associated with Infectivity and Severity. Scandinavian Journal of Immunology. 2021. doi:
https://doi.org/10.1111/sji.13039.
Zhang JX, Dong YY, Cao YD, You YB, Yang YQ, Yan CA et al. Clinical Characteristics of 140 patients infecter with SARS-CoV-2 in Wuhan China. Wiley Online Library Journal. 2020.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. doi: 10.1016/S0140-6736(20)30566-3.
Gerayeli FV, Milne S, Cheung C, Li X, Yang CWT, Tam A, et al. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis, EClinical Medicine. 2021. doi: https://doi.org/10.26553/jikm.2021.12.1.69-76.
Erener, S. Diabetes, infection risk and COVID-19, Molecular Metabolism. 2020. doi: https://doi.org/10.1016/j.molmet. 2020.101044.
Huang I, Lim M, Pranata R,. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020. doi: https://doi.org/10.1016/j.dsx.2020.04.018
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
